Showing results (1-10 of 355) with videos related to
Sort By:
Pageof 36
Blood|December 30, 2015
Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemiaWeiwei Shen, Mrinal M Patnaik, Autumn Ruiz, et al.Current HIV Research|March 6, 2010
The Vpu protein: new concepts in virus release and CD4 down-modulationAutumn Ruiz, John C Guatelli, Edward B StephensVirology|December 11, 2012
Simian-Human immunodeficiency viruses expressing chimeric subtype B/C Vpu proteins demonstrate the importance of the amino terminal and transmembrane domains in the rate of CD4(+) T cell loss in macaquesAutumn Ruiz, Kimberly Schmitt, Nathan Culley, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 15, 2007
History of oncolytic viruses: genesis to genetic engineeringElizabeth Kelly, Stephen J RussellExpert Reviews in Molecular Medicine|September 25, 2004
Parvovirus vectors: use and optimisation in cancer gene therapyBoris Blechacz, Stephen J RussellExpert Opinion on Biological Therapy|October 6, 2004
Oncolytic measles viruses for cancer therapyTakafumi Nakamura, Stephen J RussellExpert Opinion on Biological Therapy|October 13, 2015
The use of the NIS reporter gene for optimizing oncolytic virotherapyAmber Miller, Stephen J RussellVirology|December 1, 2009
Identification of amino acids within the second alpha helical domain of the human immunodeficiency virus type 1 Vpu that are critical for preventing CD4 cell surface expressionM Sarah Hill, Autumn Ruiz, Kimberly Schmitt, et al.Pageof 36